China Life Sciences Investment Opportunities Attract Cross Border Tie Ups
This article was originally published in PharmAsia News
Executive Summary
HONG KONG - As China ramps up to overtake Japan as the No. 2 pharmaceutical market in coming years, investors are entering the foray to get a foothold in the burgeoning China pharma market and some interesting partners are joining forces